Biosimilar Legal Roundup: November 2020
November 30, 2020
Skylar Jeremias
ArticleIn November, the Supreme Court heard arguments on the Affordable Care Act, Europe fired up its efforts to create a more biosimilar-friendly environment, and Genentech fought to protect its bevacizumab franchise.